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Oligodendrocyte precursor cells (OPCs) can be differentiated in culture into either oligodendrocytes or type-2 astrocytes (2As), depending
on the culture conditions. Whereas oligodendrocyte development can occur in the absence of inducing signals, 2A development apparently
cannot. Fetal calf serum (FCS) and bone morphogenetic proteins (BMPs) are powerful inducers of 2A development in culture, but there is no
compelling evidence that OPCs develop into astrocytes in vivo. We show here that BMPs are made by glial cells in the developing rat optic
nerve, raising the question of why 2As do not normally develop in the optic nerve. We demonstrate that the BMP antagonist Noggin is
strongly expressed by both OPCs and type-1 astrocytes in the developing optic nerve. We also show that depletion of Noggin by a small
interference RNA inhibits OPC proliferation and induces 2A differentiation in the presence of a low, non-2A-inducing concentration of FCS.
By contrast, enforced expression of Noggin in OPCs blocks FCS-induced 2A differentiation. These findings suggest that BMPs in FCS are
largely responsible for the 2A-inducing activity of FCS and that Noggin may normally inhibit the formation of 2As in the developing CNS.
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Oligodendrocyte precursor cells (OPCs) are arguably the
best-characterized precursor cells in the vertebrate CNS. In
serum-free culture, OPCs develop into oligodendrocytes and
seem not to require extracellular inducing signals to do so
(Temple and Raff, 1985). When cultured in 10% fetal calf
serum (FCS), however, they rapidly differentiate into a
special type of astrocyte, called a type-2 astrocyte (2A),
which expresses glial fibrillary acidic protein (GFAP) and
extends multiple cell processes (Lillien and Raff, 1990a,
Raff et al., 1983). For this reason, OPCs were originally
called O-2A progenitor cells (Raff et al., 1984). Besides
FCS, several signal proteins have been shown to induce 2A
differentiation, including CNTF (Hughes et al., 1988; Lil-
lien et al., 1988), the CNTF-related proteins LIF and0012-1606/$ - see front matter D 2003 Published by Elsevier Inc.
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proteins (BMPs) (Mabie et al., 1997). CNTF and its
relatives, however, induce only transient GFAP expression,
and the OPCs subsequently develop into oligodendrocytes:
if the OPCs are cultured on extracellular matrix derived
from meningeal or endothelial cells, however, CNTF indu-
ces stable 2A differentiation (Gard et al., 1995, Lillien and
Raff, 1990b; Lillien et al., 1990). BMPs, by contrast, can
induce stable 2A differentiation, even if OPCs are exposed
to them for only a short period (Mabie et al., 1997).
Interest in 2As faded when attempts to demonstrate them
in vivo failed (Fulton et al., 1992; Skoff, 1990), raising the
possibility that 2As are a cell culture artefact. Our interest in
2As, however, was reawakened when we found that OPCs
induced to differentiate into 2As by treatment with BMPs or
FCS, and then cultured in basic FGF (bFGF) could acquire
characteristics of neural stem cells (NSCs) (Kondo and Raff,
2000). The induction to 2As seemed to be required for
OPCs to convert to NSCs, as freshly isolated OPCs prolif-
erating in bFGF did not acquire the ability to generate
neurons.
It remains a mystery why OPCs do not develop into 2As
in the CNS, as 2A-inducing signals such as BMPs are
present in various parts of the developing CNS. Indeed,
T. Kondo, M.C. Raff / Developmentathere is strong evidence that BMPs play important parts in
cell-fate choice in both the CNS (Ebendal et al., 1998;
Gomes et al., 2003; Mehler et al., 2000) and peripheral
nervous system (Shah et al., 1996).
In the present study, we have investigated this mystery in
the rat optic nerve. We show that small numbers of cells in
suspensions prepared from postnatal nerve express both
oligodendrocyte lineage markers and GFAP, suggesting that
some OPCs can respond to 2A inducers in the nerve. We
also show that glial cells in the developing nerve express
both BMPs and the BMP antagonists, Noggin and Chordin.
Finally, we demonstrate that the depletion of Noggin by a
specific small interference RNA (siRNA) causes OPCs to
proliferate more slowly and promotes their differentiation
into 2As. By contrast, overexpression of Noggin in OPCs
inhibits 2A differentiation induced by FCS. These findings
suggest that glial-cell-derived Noggin may help ensure that
OPCs in the CNS do not normally become 2As or neural
stem cells.Materials and methods
Animals and chemicals
Sprague–Dawley rats were obtained from the Animal
Facility at University College London. Chemicals were
purchased from Sigma, except where indicated. Recombi-
nant human PDGF-AA and human BMP2 were purchased
from Peprotech.
Dissociation and purification of optic nerve glial cells
Optic nerve cells were dissociated from postnatal rats as
previously described (Barres et al., 1992). In some experi-
ments, unpurified optic nerve cells were cultured on poly-D-
lysine (PDL)-coated glass coverslips for 2–3 h before they
were fixed and stained. For most experiments, postnatal day
6 (P6) rat OPCs and oligodendrocytes were purified to
>98% purity by sequential immunopanning as described
previously (Barres et al., 1992). Type-1 astrocytes (1As)
were also purified by sequential immunopanning, as previ-
ously described (Mi and Barres, 1999). The purified cells
were cultured in PDL-coated 6-well culture dishes for clonal
density culture (1000 cells per flask) (Falcon) or slide flasks
for immunolabeling (Nunc). All cells were cultured in
serum-free Dulbecco’s Modified Eagle’s medium containing
bovine insulin (10 Ag/ml), human transferrin (100 Ag/ml),
BSA (100 Ag/ml), progesterone (60 ng/ml), putrescine (16
Ag/ml), sodium selenite (40 ng/ml), N-acetylcysteine (60 Ag/
ml), forskolin (5 AM), PDGF-AA (10 ng/ml), penicillin, and
streptomycin (GIBCO) (culture medium). To induce 2A
differentiation, purified P6 OPCs were cultured in the
presence of FCS (10%) or BMP2 (10 ng/ml) for various
periods of time. If cultures were maintained for longer than
4 days, half of the medium was replaced every 2 days.RT-PCR analysis
Cells were harvested by trypsinization, and poly(A)+
RNA was prepared using a QuickPrep Micro mRNA Puri-
fication kit (Pharmacia Biotech); 1.5 Ag of partially purified
poly(A)+ RNA was reverse transcribed in 33 Al of reaction
mixture, using a First-Strand cDNA Synthesis kit (Pharma-
cia Biotech). The RT-PCR reaction was carried out in a 50-
Al reaction mixture that contained 3 Al of cDNA as template,
1 AM of the specific oligonucleotide primer pair, and 1.25
units of Taq DNA polymerase. In the assays for bmp
receptor (bmpr) mRNAs, DMSO (5%) was added to the
reaction mixture. Cycle parameters for noggin, chordin,
bmp2, or bmp4 cDNA were 30 s at 94jC, 30 s at 63jC,
and 2 min at 72jC for 33 cycles. For bmpr-Ia, bmpr-Ib, and
bmpr-II, they were 10 s at 94jC, 20 s at 53jC, and 45 s at
72jC for 30, 35, or 30 cycles, respectively. For b-actin, they
were 15 s at 94jC, 30 s at 53jC, and 1 min at 72jC for 23
cycles. The identity of the amplified products was checked
by digestion with appropriate restriction enzymes.
The following oligonucleotide DNA primers were syn-
thesized: For rat noggin, the 5V primer was 5V-TTGAATT-
CATGGAGCGCTGCCCCAGCCT-3V, and the 3Vprimer was
5V-GGGTCGACCTAGCAGGAACACTTACACTCGG-3V.
For rat chordin, we used conserved sequences between
h um a n a n d m o u s e ; t h e 5 V p r i m e r w a s 5 V-
GGAGGCCTGCGCCTGGCCTC-3V, and the 3Vprimer was
5V-ACACTGCACCTTCTCAGAGTGCA-3V. For rat bmp2,
t h e 5 V p r ime r wa s 5 V- TTGGATCCATGGTGG-
CCGGGACCCGCTG-3V, and the 3V primer was 5V-
TTCTCGAGCTAGCGACACCCGCAACCCTC-3V. For rat
bmp4, we used conserved sequences between human and
mouse; the 5V primer was 5V-AAGGATCCATGATTCC-
TGGTAACCGAATGCTGA-3V, and the 3V primer was 5V-
TTCTCGAGTCAGCGGCATCCACACCCCTC-3V. For rat
bmpr-Ia, the 5V primer was 5V-CAGACTTGGACCAGAA-
GAAGCC-3V, and the 3V primer was 5V-ACATTCTATTGT-
CTGCGTAGC-3V. For rat bmpr-Ib, the 5V primer was 5V-
AAGAAGATGACTCTGGAATGCC-3V, and the 3V primer
was 5V-ATCCACACCTCGCCATAGCG-3V. For rat bmpr-II,
the 5V primer was 5V-AGGGAACGGCCATTAGAAGGT-3V,
and the 3V primer was 5V-TCACAGACAATTCATTCCTA-
TATC-3 V. For rat b-actin , the 5 V primer was 5 V-
TGGAATCCTGTGGCATCC-3V, and the 3V primer was 5V-
TCGTACTCCTGCTTGCTG-3V.
Full length mouse noggin cDNA was amplified from
mouse total brain cells, using RT-PCR and pfu Turbo
polymerase (Invitrogen). The cDNA was cloned into a
pMOSBlue vector (Amersham Pharmacia Biotech). The
nucleotide sequences were determined using a BigDye
terminator kit and an ABI sequencer (model 310).
Retrovirus vectors
To deplete or overexpress noggin mRNA in OPCs and
to mark the transfected cells, we made recombinant
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Table 1
GFAP+ oligodendrocyte lineage cells in 2–3 h of cultures of P13 optic
nerve cells
Percentage of GFAP+ cells expressing
A2B5 NG-2 O4
5 F 3 6 F 2 0.5 F 0.3
Freshly dissociated P13 rat optic nerve cells were cultured in serum-free
medium for 2–3 h at 37jC. They were then fixed with paraformaldehyde,
surface stained with one of the three antibodies indicated, fixed in acid-
alcohol, and then stained for GFAP. The results are shown as mean F SD
of the results from three experiments.
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vector (kindly provided by Dr. Kitamura; Misawa et al.,
2000). We constructed vectors encoding green fluores-
cence protein (GFP) and either U6-promoter-driven
siRNA for noggin (pMY-GFP-Nog-siRNA) or mouse
Noggin (pMY-GFP-Nog). The synthesized noggin siRNA
oligonucleotides were 5V-GAAGCTGAGGAGGAAGT-
TATTCAAGAGATAACTTCCTCCTCAGCTTCTTTTT-3V
and 5V-AAAAAGAAGCTGAGGAGGAAGTTATCTCTT-
GAATAACTTCCTCCTCAGCTTC-3V.
The vectors were used to transfect PLATE packaging
cells (Misawa et al., 2000) using TransIT 293 (Mirus), and
culture supernatants were harvested 2 days after transfec-
tion. To concentrate the recombinant virus, culture super-
natant was centrifuged at 6000 rpm for 16 h (Misawa et al.,
2000). The virus pellet was suspended in serum-free medi-
um, and the virus solution was used to infect P6 OPCs in
either mass- or clonal-cultures. The cells were cultured with
the recombinant retrovirus overnight, washed, and then
cultured in the same medium for a further 2 days. Infection
efficiency was normally >80%. In some cases, the cells were
then cultured with PDGF and FCS for 5 days to induce the
cells to differentiate into 2As.
Immunocytochemistry
For immunostaining, freshly isolated cells from P13 rat
optic nerve were cultured for 2–3 h on PDL-coated cover-
slips, or purified P6 OPCs were cultured in slide flasks in
PDGF alone or PDGF plus BMP for 4 days. The cells were
fixed in 2% paraformaldehyde for 4 min at room tempera-
ture (RT) and then surface-labeled either with A2B5 (Eisen-
barth et al., 1979) or O4 (Sommer and Schachner, 1981)
monoclonal antibody (ascites fluid, diluted 1:100), followed
by biotin-coupled goat anti-mouse immunoglobulin (Amer-
sham, diluted 1:100), or with rabbit anti-rat NG2 proteo-
glycan antibodies (gift from William Stallcup; diluted
1:1000) (Nishiyama et al., 1996), followed by biotin-cou-
pled goat anti-rabbit Ig (Amersham; diluted 1:100). The
biotin-coupled antibodies were detected with Texas Red-
coupled streptavidin (Amersham, diluted 1:100). The cells
were then fixed in acid-alcohol and stained with rabbit anti-
GFAP antibodies (Pruss, 1979; diluted 1:100), followed by
FITC-coupled sheep anti-rabbit Ig (Wellcome, diluted
1:100). Incubations were for 25 min at RT, and the anti-
bodies were diluted in minimal Eagle’s medium with 0.02
M HEPES buffer containing 10% FCS and 0.2% (w/v)
sodium azide.
To examine the expression of Noggin protein in cryo-
sections of optic nerve or in purified glial cells, the sections
or cells were fixed with 2% paraformaldehyde for 10 min at
RT and then treated with 50% normal goat serum plus 0.1%
Triton X-100. The sections or cells were then immunos-
tained with rat monoclonal anti-Noggin antibody (gift from
Regeneron Pharmaceuticals; 2 Ag/ml), followed by biotin-
conjugated goat anti-rat IgG (Jackson ImmunoResearch;diluted 1:100) and then FITC-conjugated streptavidin
(Amersham Pharmacia; diluted 1:100). In some experi-
ments, retrovirus infected OPCs were immunolabeled with
the rat monoclonal anti-Noggin antibody and rabbit anti-
GFP antibodies (Molecular Probe; diluted 1:200), followed
by FITC-conjugated goat anti-rabbit IgG (Jackson Immu-
noResearch; diluted 1:100) and Texas Red-conjugated goat
anti-rat IgG (Jackson ImmunoResearch; diluted 1:100). To
visualize all nuclei, the sections or cells were stained with
propidium iodide (PI; 1 Ag/ml) or Hoechst 33342 dye (1 Ag/
ml). The stained sections or cells were mounted in Citifluor
mounting medium (CitiFluor, UK), sealed with nail varnish,
and examined in a Zeiss Axioplan fluorescence microscope.
ELISA assay
To quantify BMP4 secreted by optic nerve glial cells, 105
mixed P6 optic nerve cells or purified glial cells were
cultured on PDL-coated 6-well dishes (Falcon) in serum-
free medium for 3 days. BMP4 in the medium was quan-
tified using an ELISA assay kit for human BMP4 (R and D
systems).Results
Some oligodendrocyte lineage cells in the P13 rat optic
nerve are GFAP+
To detect OPCs in suspensions prepared from P13 rat
optic nerve, we cultured freshly dissociated cells for 2–3
h and then surface stained them with the A2B5 monoclonal
antibody or rabbit anti-NG2 antibodies to identify OPCs
(Nishiyama et al., 1996; Raff et al., 1983). To determine if
any of these cells expressed GFAP, we then fixed them in
acid-alcohol and stained them with anti-GFAP antibodies.
As shown in Table 1, 5% of A2B5+ cells (Figs. 1A–C) and
6% of NG-2+ cells (Figs. 1D–F) were immunolabeled for
GFAP. Almost all of these double-stained cells were only
weakly GFAP+ and had a process-bearing morphology, and
they were readily distinguishable from the intensely GFAP+
type-1 astrocytes (1As), which were not surface labeled
(Fig. 1F).
Fig. 1. Immunofluorescence staining of P13 rat optic nerve cells cultured for 2–3 h. The cells were surface-stained for A2B5 (B), NG2 (E), and O4 (H), and
then fixed in acid-alcohol and stained for GFAP (C, F, I). The same cells are shown in A–C, in D–F, and in G–I. Phase-contrast micrographs were shown in
A, D, and G. Scale bar, 20 Am.
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monoclonal antibody, which labels mature OPCs and oli-
godendrocytes (Gard and Pfeiffer, 1990; Sommer and
Schachner, 1981), and then fixed the cells and stained them
for GFAP. Only 0.5% of O4+ cells were GFAP+ (see Table
1), and they tended to have an oligodendrocyte-like mor-
phology (Figs. 1G–I). Almost all of the O4/GFAP+ cells
were intensely GFAP+ and did not have a process-bearing
morphology (Fig. 1I).
When P2 optic nerve cells were cultured for 2–3 h and
stained in the same ways, none of the GFAP+ cells were
A2B5 +, NG2 +, or O4 + (not shown).
Extracts of rat optic nerve have been shown to induce
OPCs in serum-free newborn optic nerve cell cultures to
express GFAP within 24 h (Hughes and Raff, 1987). It was,
therefore, possible that the weakly GFAP+ process-bearing
cells in our cultures of P13 optic nerve cells were OPCs that
were induced to express GFAP during the 2–3 h of culture
period. To test this possibility, newborn optic nerve cells,
which are more sensitive to the GFAP-inducing activity of
optic nerve extracts than are older optic nerve cells (Hughes
and Raff, 1987), were cultured in serum-free medium in the
presence of an extract of 3-week-old rat optic nerve for 24 h.
As described previously (Hughes and Raff, 1987), approx-
imately 30% of the A2B5+ process-bearing cells became
GFAP+ after 24 h in vitro, but none of the A2B5+ process-bearing cells were GFAP+ after only 3 h in vitro (not
shown). It therefore seems likely that the weakly GFAP+
process-bearing cells in the 2–3 h of cultures of P13 optic
nerve were induced to express GFAP while in the develop-
ing nerve, rather than while in culture, suggesting that at
least some OPCs in vivo can respond to 2A-inducing
factors.
All optic nerve glial cells express bmp2 or bmp4
CNTF (Hughes et al., 1988; Lillien et al., 1990) and its
relatives oncostatin-M and LIF (Gard et al., 1995), as well
as BMPs (Mabie et al., 1997), have been shown to induce
GFAP expression in OPCs in culture. Whereas CNTF and
its relatives induce only transient GFAP expression in
OPCs, unless used in the presence of extracellular matrix
produced by meningeal or endothelial cells (Gard et al.,
1995; Hughes et al., 1988; Lillien et al., 1990), BMPs on
their own can induce stable 2A differentiation (Mabie et al.,
1997). Moreover, it has been shown that the overexpression
of a bmp4 transgene driven by a neuron-specific enolase
promoter in transgenic mice decreases oligodendrocyte
development and increases astrocyte development, without
apparently influencing neuronal development (Gomes et al.,
2003). Thus, it is possible that excessive BMP signaling can
direct some OPCs in vivo to develop into 2As instead of
T. Kondo, M.C. Raff / Developmental Biology 267 (2004) 242–251246into oligodendrocytes. By contrast, overexpression of CNTF
in transgenic mice was reported not to have observable
effects on oligodendrocyte development (Winter et al.,
1995).
We therefore examined whether BMPs are produced by
developing rat optic nerve cells. We first purified P6
oligodendrocytes, OPCs, and 1As by sequential immuno-
panning (Barres et al., 1992; Mi and Barres, 1999) and used
RT-PCR to examine the expression of the mRNAs that
encode BMP2 and BMP4. As shown in Fig. 2A, bmp2
mRNA was weakly expressed in 1As but not in either
oligodendrocytes or OPCs. By contrast, both oligodendro-
cytes and OPCs, but not 1As, strongly expressed bmp4
mRNA.
To determine whether developing optic nerves cells
(ONCs) secreted BMP4 protein, we dissociated P6 optic
nerve cells and cultured 105 of them on PDL-coated 6-well
dishes for 3 days in serum-free medium. We then assayed theFig. 2. BMP4 expression in rat optic nerve glial cells in culture. (A)
Different types of glial cells were purified from P6 rat optic nerves by
sequential immunopanning, and bmp2, bmp4, and b-actin mRNAs were
analyzed by RT-PCR immediately after purification. (B) One hundred
thousand mixed P6 optic nerve cells (ONCs) or purified P6 OPCs,
oligodendrocytes (OLGs), or 1As were cultured in serum-free medium with
PDGF for 3 days. BMP4 in the medium was quantified by an ELISA assay.culture medium for BMP4 using an ELISA assay. As shown
in Fig. 2B, the medium contained 22 F 4 pg/ml of BMP4.
To determine which cell types in the optic nerve secrete
BMP4, we purified the different cell types by sequential
immunopanning, cultured 105 of the purified cells for 3
days, and assayed the culture medium for BMP4 as just
described. As shown in Fig. 2B, whereas 1As did not secrete
detectable amounts of BMP4, the medium from purified
OPCs contained 9 F 2 pg/ml of BMP4, and the medium
from purified oligodendrocytes contained 52 F 6 pg/ml.
Thus, developing OPCs and oligodendrocytes make bmp4
mRNA and secrete the protein, whereas developing 1As do
neither, although they express bmp2 mRNA.
Purified OPCs express BMP receptor mRNAs and
differentiate into 2As in the presence of BMP
We next used RT-PCR to determine whether purified P6
OPCs express bmp receptor (bmpr) mRNAs. As shown in
Fig. 3A, OPCs and oligodendrocytes expressed both bmpr
type Ia (bmpr-Ia) and type II (bmpr-II) mRNAs. By contrast,
OPCs expressed bmpr type Ib (bmpr-Ib) mRNA only
weakly, and oligodendrocytes did not express it at all. These
findings are consistent with previous results using immu-
nolabeling to demonstrate both BMPR-I and -II on OPCs
(Mabie et al., 1997).
We then tested whether OPCs could respond directly to
BMPs by differentiating into 2As. As shown in Figs. 3C,
D, when purified OPCs were cultured in the presence of
BMP2 for 4 days, over 90% of the cells differentiated into
typical GFAP+ 2As. The findings that OPCs have receptors
for BMPs and can respond directly to BMPs by becoming
2As raise the question of why secreted BMPs do not
induce OPCs to differentiate into 2As in the developing
optic nerve.
All optic nerve glial cells express at least one BMP
antagonist
In early neural development, BMPs are produced in the
dorsal region of the neural tube, whereas the BMP antag-
onists Noggin and Chordin are produced ventrally by the
notochord. In this way, a gradient (dorsal high, ventral low)
of BMP4 signaling is established, which helps pattern the
neural tube (Jessell and Sanes, 2000; Sasai and De Robertis,
1997). Homozygous Noggin-deficient mice die perinatally
with severe defects in the ventral ventricular zone, whereas
homozygous Chordin-deficient mice are viable in outbred
backgrounds, although the mice have mild defects of the
cranium and cervical vertebrae (Bachiller et al., 2000;
Brunet et al., 1998; McMahon et al., 1998). Since OPCs
arise from the ventral ventricular zone of the developing
neural tube and migrate throughout the CNS (Noll and
Miller, 1993; Pringle and Richardson, 1993; Timsit et al.,
1995), Noggin seemed a possible candidate for neutralizing
the activity of BMPs in the developing optic nerve.
Fig. 3. Purified OPCs express BMP receptor mRNAs and are induced by BMP2 to differentiate into 2As. (A) OPCs were purified from P6 optic nerve by
immunopanning, and bmpr-Ia, bmpr-Ib, bmpr-II, and b-actin mRNAs were analyzed by RT-PCR immediately after purification. (B) Purified P6 OPCs were
cultured at clonal density in PDGF alone (B) or PDGF plus BMP2 (C) on PDL-coated slide flasks for 4 days and then labeled for A2B5 (red) and GFAP
(green), and with Hoechst dye 33342 to identify all nuclei (blue). Scale bar, 25 Am. (C) The proportion of GFAP positive cells in A2B5 positive cells is shown
as the mean F SD of three cultures (500 clones of each culture). *P < 0.01 in comparison with the result of control cultures, when analyzed by Student’s t test.
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developing nerve, we immunolabeled cryosections of P6
optic nerve with anti-Noggin antibody. As shown in
Fig. 4A, the nerves were clearly immunostained for
Noggin, with increasing intensity near the surface of the
nerve.
To determine which cell types in the optic nerve express
mRNAs encoding BMP antagonists, we purified P6 oligo-Fig. 4. Noggin and Chordin expression in rat optic nerve glial cells. (A and B) P6
either a rat monoclonal anti-Noggin antibody (A, green, top panel) or normal rat
label all nuclei (red, middle panels). The fused images are shown in the bottom p
nerve by immunopanning and noggin, chordin, and b-actin mRNAs were analyzed
(E), or oligodendrocytes (F) were cultured on PDL-coated slide flasks for 2 day
panels). Note that a contaminating oligodendrocyte is weakly labeled for Noggin in
Am in A and B, 25 Am in D–F.dendrocytes, OPCs, and 1As by sequential immunopanning,
extracted mRNA from the freshly purified cells, and used
RT-PCR to examine the expression of noggin and chordin
mRNAs. As shown in Fig. 4C, noggin mRNAwas strongly
expressed in both OPCs and 1As and weakly expressed in
oligodendrocytes. Chordin mRNAwas weakly expressed by
OPCs and 1As and was not detectably expressed by
oligodendrocytes. Together, these findings suggest thatoptic nerves were fixed, frozen, sectioned longitudinally, and stained with
serum (B, top panel). They were also stained with propidium iodide (PI) to
anels. (C) The different types of glial cells were purified from P6 rat optic
by RT-PCR immediately after purification. (D–F) Purified OPCs (D), 1As
s and then stained for Noggin (green, top panel) and with PI (red, middle
E (arrow). The fused images are shown in the bottom panels. Scale bar, 300
T. Kondo, M.C. Raff / Developmental Biology 267 (2004) 242–251248Noggin is likely to be the main BMP antagonist produced in
the developing rat optic nerve.
To determine which cell types in the optic nerve express
Noggin protein, we purified the different cell types by
sequential immunopanning, cultured them on PDL-coated
slide flasks for 2 days, and immunostained them with anti-
Noggin antibody. We readily detected Noggin in both OPCs
(Fig. 4D) and 1As (Fig. 4E) but could barely detect it in
oligodendrocytes (Figs. 4E, F). Taken together, these results
suggest that Noggin (and perhaps Chordin) produced by
OPCs and 1As might neutralize the activity of BMP4
produced by OPCs and oligodendrocytes and BMP2 pro-
duced by 1As and thereby inhibit 2A differentiation in the
developing optic nerve.
Noggin is an inhibitor of 2A differentiation
To examine further the possible role of Noggin in 2A
differentiation, we made three types of recombinant retro-
viruses—a control virus encoding GFP alone (vC), one
encoding siRNA for Noggin (vNog-siRNA) and one encod-
ing mouse Noggin (vNog). Purified OPCs were infectedFig. 5. Effects of Noggin depletion in OPCs. Cultures of purified P6 rat OPCs wer
virus (B). They were then washed, cultured in PDGF for 3 days, and immunostain
33342 dye to identify all nuclei (blue). The fused images are shown in the bottom
apoptotic, as assessed by nuclear morphology (arrowheads). Scale bar, 25 Am. (C)
were cultured at clonal density in PDGF for 14 days. The number of cells in each
clones assessed for each virus. *P < 0.001 in comparison with the result of vC-in
cells in slide flask) infected as in A and B were cultured in PDGF for 2 days and
cells that were GFAP+ are shown as the mean F SD of three cultures (50–100 c
siRNA-infected cells, when analyzed by Student’s t test.with virus overnight, washed, and then cultured in PDGF
for further 2 days. The cells were then fixed and immunos-
tained for both Noggin and GFP, and their nuclei were
stained with Hoechst dye.
Compared to infection with the control virus (Fig. 5A),
infection with the vNog-siRNA virus (Fig. 5B) greatly
reduced the expression of endogenous Noggin. Using the
vNog-siRNA virus, we then tested whether depletion of
Noggin induced OPCs to differentiate into 2As. We infected
purified OPCs with either vC or vNog-siRNA and then
cultured them in PDGF for a further 14 days. Noggin
depletion in OPCs was not enough to induce 2A differen-
tiation (not shown), but it was enough to decrease OPC
proliferation. As shown in Fig. 5C, the average cell number
in vNog-siRNA-infected clones was seven times less than
that in vC-infected clones. As there was not a detectable
increase in cell death in the vNog-siRNA-infected clones
(about 5% of the cells were apoptotic in both vC- and vNog-
siRNA-infected clones), this finding suggests that endoge-
nous BMP4 produced by the purified OPCs normally limits
their own proliferation and that Noggin produced by OPCs
normally counters this effect.e infected overnight with either the vC control virus (A) or the vNog-siRNA
ed for Noggin (red) and GFP (green). They were also stained with Hoechst
panels. In both control and siRNA cultures, 3–5% of the GFP+ cells were
Purified P6 OPCs (1000 cells in 25 cm2 culture flask) infected as in A and B
GFP-expressing clone was counted and is shown as the mean F SD of 50
fected cells, when analyzed by Student’s t test. (D) Purified P6 OPCs (1000
then in 2.5% FCS and PDGF for a further 5 days. The proportions of GFP+
lones of each culture). **P < 0.01 in comparison with the result of vNog-
Fig. 6. Effects of Noggin overexpression in OPCs. Clonal-density cultures of purified P6 rat OPCs (1000 cells in slide flask) were infected overnight with either
the vC control virus or the vNog virus. They were cultured in PDGF for another 2 days and then in 5% FCS for a further 5 days to induce 2A differentiation.
They were then immunostained for GFAP. (A) The proportion of GFP+ cells that were GFAP+ is shown as the mean F SD of three cultures (50–100 clones of
each culture). *P < 0.01 in comparison with the result of vC-infected cells, when analyzed by Student’s t test. (B and C) Fluorescence micrographs illustrating
the effect of Noggin overexpression on 2A differentiation induced by FCS. The cells were infected with either the vC (B) or the vNog (C). Scale bar, 25 Am.
T. Kondo, M.C. Raff / Developmental Biology 267 (2004) 242–251 249Although knocking down Noggin did not induce 2A
development on its own, it did increase the sensitivity of
OPCs to the 2A-inducing activity of FCS. When we
cultured purified OPCs infected with either vC or vNog-
siRNA in 2.5% FCS for 5 days, about 30% of vC-infected
cells became GFAP+, whereas about 70% of vNog-siRNA-
infected cells became GFAP+ (Fig. 5D). This result suggests
that the 2A-inducer(s) in FCS may be BMPs. Together,
these findings suggest that Noggin may normally promote
OPC proliferation and inhibit 2A differentiation by neutral-
izing the activity of BMPs.
To examine further the role of BMPs in FCS-induced 2A
differentiation, we infected purified OPCs overnight with
either vC or the Noggin-encoding virus vNog, washed the
cells, cultured them in the same medium with 5% FCS for 5
days, and then immunostained them for GFAP. As shown in
Fig. 6, whereas over 70% vC-infected cells became GFAP+
(Fig. 6A) and acquired the characteristic morphological
features of 2As (Fig. 6B), less than 15% of the vNog-
infected cells did so (Figs. 6A, C). This finding supports the
suggestion that BMPs in FCS are largely responsible for
inducing 2A differentiation.Discussion
In culture at least, OPCs are bipotential in that they can
develop into either oligodendrocytes or 2As, depending on
the culture conditions (Raff et al., 1983). Whereas oligo-
dendrocyte differentiation in culture can occur in the ab-
sence of exogenous inducing signals, 2A differentiation
apparently cannot. At least three types of 2A inducers have
been reported—FCS, CNTF and its relatives, and BMPs(Gard et al., 1995; Hughes et al., 1988; Lillien et al., 1988;
Mabie et al., 1997; Raff et al., 1983). Although CNTF is
produced in the developing rat optic nerve (Stockli et al.,
1991), it is not a typical secretory protein and may only be
released after injury (Sendtner et al., 1994), which may be
one reason why 2As normally do not develop in the optic
nerve (Fulton et al., 1992; Skoff, 1990). The few A2B5+/
GFAP+ and NG2+/GFAP+ cells that we observe in the P13
rat optic nerve in the present study seem more likely to be
OPCs that have been induced to express GFAP transiently
rather than bona fide 2As. In the absence of appropriate
extracellular-matrix-associated factors, CNTF and its rela-
tives induce only transient GFAP expression in OPCs (Gard
et al., 1995; Lillien et al., 1990).
We show here, however, that BMPs, which are typical
secreted proteins and on their own can induce stable 2As in
culture (Mabie et al., 1997), are also produced in the devel-
oping optic nerve. We show that BMP4 is made mainly by
OPCs and oligodendrocytes, whereas BMP2 is made mainly
by 1As. We also show that purified OPCs express both bmpr-
Ia and -IImRNAs. Why then do the BMPs in the optic nerve
not induce OPCs to develop into 2As? Our finding that the
secreted BMP antagonist Noggin (and to a lesser extent
Chordin) is made in the developing optic nerve, mainly by
OPCs and 1As, provides an attractive possible answer. As
1As begin to differentiate before OPCs migrate into the optic
nerve in substantial numbers (Mi and Barres, 1999; Raff et
al., 1984), it seems likely that Noggin would effectively
neutralize the activity of the BMPs.
We also show that overexpression of Noggin in purified
OPCs greatly decreases their differentiation into 2As in-
duced by FCS. This finding strongly suggests that BMPs in
FCS are largely responsible for the 2A-inducing activity of
T. Kondo, M.C. Raff / Developmental Biology 267 (2004) 242–251250FCS. It was shown previously that BMPs are secreted by
hematopoietic cells (Detmer et al., 1999) and are abundant
in the serum of growing children (Urist and Hudak, 1984;
Urist et al., 1985). Moreover, we find that knocking down
the levels of Noggin produced by purified OPCs using
Noggin siRNA increases the sensitivity of the OPCs to
the 2A-inducing effect of FCS. This finding raises the
possibility that Noggin normally inhibits the development
of OPCs into 2As in vivo. The previous finding that the
expression of bmp4 transgene from a neuron-specific eno-
lase promoter increases astrocyte development and
decreases oligodendrocyte development in the mouse CNS
is consistent with this possibility (Gomes et al., 2003). We
also find that the knock down of Noggin in purified OPCs
greatly decreases their proliferation in culture, raising the
possibility that BMPs may normally limit the proliferation
of OPCs in vivo and that Noggin normally counters this
effect. This result is consistent with previous findings that
BMPs can inhibit cell proliferation by inducing the accu-
mulation of the cyclin-dependent kinase inhibitors p21/Cip1
and p27/Kip1 (Nakamura et al., 2003; Nakaoka et al., 1997;
Wong et al., 2003). Our findings are also consistent with a
previous study that showed that Noggin increases oligoden-
drocyte development in cultures of embryonic day 16
cortical precursors (Mehler et al., 2000). Noggin-deficient
mice die at birth, before oligodendrocytes develop, but they
have severe CNS defects (McMahon et al., 1998), indicating
that Noggin is crucial for normal CNS development.
It seems likely that the balance between BMPs and their
antagonists help regulate the development of OPCs. In the
optic nerve, for example, the production of Noggin may
prevent BMPs from inducing OPCs to develop into 2As. As
2As can convert into multipotential neural stem cells in the
presence of bFGF (Kondo and Raff, 2000), BMP antagonists
may also normally prevent OPCs from becoming such stem
cells in vivo. In the future, it will be important to use
conditional gene inactivation to study the influence of BMPs
and their various antagonists on OPC development in the
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